Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue...
Drug safety advice
- Clopidogrel and proton pump inhibitors: interaction
- Abacavir: risk of myocardial infarction - update from epidemiological studies
Yellow Card scheme update
- You can report side effects and adverse drug interactions on a Yellow Card
Hot topic
- Use of long-acting β-agonists in chronic obstructive pulmonary disease
Stop press
- Mycophenolate mofetil: pure red cell aplasia
- Hydroxycut range of food supplements: risk of liver damage
- Priadel Liquid: potential for dosing errors
- Clarification: ACE inhibitors and angiotensin II receptor antagonists - use during breastfeeding
Other information from the MHRA
- Patient Information Leaflet of the month: sulfasalazine
- Consultation: proposals to strengthen and rationalise EU pharmacovigilance
Drug Safety Update: Volume 2 Issue 12, July 2009 
